Exchange Traded Concepts LLC Cuts Stock Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Exchange Traded Concepts LLC lowered its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 12.9% during the third quarter, Holdings Channel reports. The fund owned 18,688 shares of the real estate investment trust’s stock after selling 2,758 shares during the period. Exchange Traded Concepts LLC’s holdings in Omega Healthcare Investors were worth $761,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Omega Healthcare Investors by 0.5% during the first quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust’s stock worth $1,120,478,000 after purchasing an additional 165,105 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Omega Healthcare Investors by 7.9% during the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after purchasing an additional 272,299 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of Omega Healthcare Investors by 4.6% during the second quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust’s stock worth $110,971,000 after purchasing an additional 143,521 shares in the last quarter. LSV Asset Management grew its stake in shares of Omega Healthcare Investors by 0.7% during the second quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust’s stock worth $67,411,000 after purchasing an additional 14,000 shares in the last quarter. Finally, Daiwa Securities Group Inc. grew its stake in shares of Omega Healthcare Investors by 1,030.8% during the second quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock worth $32,384,000 after purchasing an additional 861,907 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Performance

NYSE OHI opened at $41.61 on Friday. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $41.62. The business’s 50-day moving average price is $39.71 and its 200 day moving average price is $35.23. The firm has a market cap of $10.73 billion, a P/E ratio of 31.76, a P/E/G ratio of 1.29 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The company had revenue of $252.70 million for the quarter, compared to analysts’ expectations of $205.92 million. During the same period in the prior year, the business earned $0.74 EPS. The business’s quarterly revenue was up 17.5% compared to the same quarter last year. On average, equities research analysts expect that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Monday, August 5th were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.44%. The ex-dividend date was Monday, August 5th. Omega Healthcare Investors’s dividend payout ratio is currently 204.58%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Scotiabank boosted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Berenberg Bank initiated coverage on shares of Omega Healthcare Investors in a research note on Friday. They issued a “buy” rating and a $45.00 price objective for the company. Mizuho downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and upped their price objective for the company from $34.00 to $35.00 in a research note on Thursday, July 25th. Finally, BMO Capital Markets upped their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, October 7th. Eight investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, Omega Healthcare Investors has a consensus rating of “Hold” and a consensus price target of $37.80.

Insider Buying and Selling

In related news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. In related news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.